Back to top
more

Merit Medical Systems (MMSI)

(Real Time Quote from BATS)

$95.98 USD

95.98
200,811

-1.48 (-1.52%)

Updated Sep 10, 2024 02:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (174 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

LabCorp (LH) Surpasses Q4 Earnings Estimates

LabCorp (LH) delivered earnings and revenue surprises of 1.97% and 2.05%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Add Cooper Companies (COO) Stock Now

Cooper Companies (COO) continues to benefit from strength in its business segments. Its acquisitions are likely to boost the top line further.

Quest Diagnostics (DGX) New Pact to Boost Laboratory Services

Quest Diagnostics' (DGX) recent agreement is intended to offer advanced and quality clinical laboratory services in the greater New York region and beyond.

Reasons Why You Should Retain ResMed (RMD) Stock For Now

Investors are optimistic about ResMed (RMD) owing to the increased demand for its sleep and respiratory care devices.

McKesson (MCK) Announces Availability of FDA-Cleared Drug for MCL

The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for MCL.

Thermo Fisher (TMO) Rides on Strong End Markets, New Launches

Thermo Fisher's (TMO) newly-launched Gibco CTS DynaCellect Magnetic Separation System is helping customers advance their cell and gene therapy programs.

Charles River (CRL) Introduces Novel IgY-Based ELISA Kit

Charles River's (CRL) HCP-ELISA is built on its HCP-GAPex service, enhancing the efficiency and efficacy of HCP assay development.

ResMed's (RMD) Mask Sales Drive Growth, Margin Issue Lingers

ResMed (RMD) continues to see robust demand for its market-leading mask portfolio despite being faced with challenges related to lower new patient setups from a competitor recall.

Here's Why You Should Retain Walgreens Boots (WBA) For Now

Investors are optimistic about Walgreens Boots (WBA) on continued partnership growth and a strong focus on strategic execution.

Abbott (ABT) EPD Growth Continues Amid Macroeconomic Challenges

At Abbott (ABT), Medical Device sales growth is led by strong performance in Electrophysiology, Structural Heart and Diabetes Care.

BD's (BDX) Latest Combination Test Receives the FDA's EUA

BD's (BDX) new combination test is likely to significantly aid clinicians in treating patients in the current and future respiratory virus seasons.

3 Reasons to Retain NextGen (NXGN) Stock in Your Portfolio

NextGen's (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.

LabCorp's (LH) New Launches, Planned Spinoff to Aid Growth

In terms of portfolio enhancement, LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to advance in life-changing treatments for cancer and other diseases.

Zacks Industry Outlook Highlights McKesson, AmerisourceBergen, LabCorp, Cardinal Health and Merit Medical

McKesson, AmerisourceBergen, LabCorp, Cardinal Health and Merit Medical have been highlighted in this Industry Outlook article.

Indrajit Bandyopadhyay headshot

5 Dental Supplies Stocks to Buy Amid Recovering Prospects

Here, we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors - MCK, ABC, LH, CAH and MMSI.

Hologic (HOLX) Q1 Earnings Beat Estimates, 2023 View Up

Lower COVID-19 assays sales and supply chain challenges related to semiconductor chips dent Hologic's (HOLX) top line in Q1.

Thermo Fisher (TMO) Q4 Earnings Beat Estimates, Margins Down

Robust year-over-year growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments boost Thermo Fisher's (TMO) Q4 revenues.

Integer Holdings (ITGR) Announces Solid Preliminary Q4 Revenues

Integer Holdings' (ITGR) revenue growth in the fourth quarter is likely to have been boosted by continued strong customer demand for its products.

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Investors continue to be optimistic about Nevro (NVRO), owing to its R&D edge.

MMSI or ALGN: Which Is the Better Value Stock Right Now?

MMSI vs. ALGN: Which Stock Is the Better Value Option?

Here's Why You Should Retain DaVita (DVA) Stock for Now

Investors remain optimistic about DaVita (DVA) due to the strength in its DaVita Kidney Care.

CVS Health (CVS) to Expand Health Care Access With New Pact

CVS Health's (CVS) recent collaboration establishes new Accountable Care that focuses on health equity, coordinated care and enhanced access.

QIAGEN's (QGEN) New Launch to Enhance Clinical Lab Workflow

QIAGEN's (QGEN) latest launch is expected to aid the clinical diagnostics labs to boost their performance.

Here's Why You Should Retain Veeva Systems (VEEV) Stock for Now

Veeva Systems' (VEEV) slew of product launches raises optimism about the stock.

Abbott's (ABT) New FDA Approval to Improve Patient Outcome

Abbott's (ABT) latest regulatory clearance is expected to improve the treatment of high-risk patients with aortic stenosis.